病后低血糖管理:一个海湾合作委员会共识声明
Elamin Abdelgadir1,2, Fauzia Rashid1,2, Fatheya Al Awadi1,2
1Mohamed Bin Rashid University, Dubai 505055, UAE.
Journal of the Endocrine Society
|February 6, 2026
概括
病后低血糖症 (PBH) 的管理是不一致的,由于复杂的原因和缺乏标准治疗. 这种共识为诊断和护理提供了统一的,基于证据的指导方针.
科学领域:
- 代谢和腹部手术 代谢和腹部手术
- 内分泌学 在内分泌学.
- 胃肠病学 胃肠病学
背景情况:
- 腹后低血糖症 (PBH) 是代谢和腹手术后的一个显著的晚期并发症.
- PBH表现出一系列症状,从轻度到重度的神经糖事件.
- 目前的PBH管理因复杂的病理生理学和缺乏标准化的协议而异质.
研究的目的:
- 建立一个统一的,以证据为基础的,以患者为中心的PBH管理协议.
- 在临床实践中标准化PBH的诊断和治疗.
- 解决PBH管理方法中的异质性.
主要方法:
- 一个由16名国际专家 (海湾合作委员会和欧洲) 组成的小组进行了文献审查.
- 达成共识的声明是使用Delphi方法开发的.
- 他们同意了45个陈述,涵盖了诊断,饮食管理,教育和治疗.
主要成果:
- 在全面PBH管理的45个声明上达成共识.
- 指南涵盖诊断,饮食调整,患者教育和药物治疗.
- 包括对怀孕,长期监测和临床实践的特殊考虑.
结论:
- 这些共识声明的实施将使PBH管理标准化.
- 仍然存在重大差距,包括需要PBH特异性疗法和强大的临床试验.
- 未来的研究应该专注于解决PBH护理中发现的这些差距.
相关概念视频
Cooperative Allosteric Transitions
8.8K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
8.8K
Cooperative Allosteric Transitions
3.1K
3.1K
Cooperative Allosteric Transitions
2.7K
2.7K
Cooperative Binding of Transcription Regulators
7.4K
Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome. Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form...
7.4K
Cooperative Binding of Transcription Regulators
2.6K
2.6K
Hypoglycemia and Glucagon
992
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
992


